CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments

This study provides Class IV evidence showing that adding maraviroc to the management of iatrogenic iPML/PML-IRIS does not improve the outcome.

Source: Neurology Neuroimmunology and Neuroinflammation - November 2, 2021 Category: Neurology Authors: Bernard-Valnet, R., Moisset, X., Maubeuge, N., Lefebvre, M., Ouallet, J.-C., Roumier, M., Lebrun-Frenay, C., Ciron, J., Biotti, D., Clavelou, P., Godeau, B., Du Pasquier, R. A., Martin-Blondel, G. Tags: Viral infections, Class IV, Multiple sclerosis Article Source Type: research